Co-localization of reelin and proteolytic aβpp fragments in hippocampal plaques in aged wild-type mice

Journal of Alzheimer's Disease

Volumn 19, Issue 4, 2010, Pages 1339-1357

  Doehner, Jana ^a   Madhusudan, Amrita ^a   Konietzko, Uwe ^a   Fritschy, Jean Marc ^a   Knuesel, Irene ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Amyloid plaques; A PP; Electron microscopy; Hippocampus; Immunohistochemistry; Mus musculus; Non transgenic; Pepsin treatment; Pre fibrillary oligomers; Sporadic Alzheimer's disease; Stratum lacunosum moleculare; Ultrastructure

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; REELIN;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERNEURON; LONG TERM MEMORY; MICROSCOPY; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; SENILE PLAQUE;

EID: 77950363927     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1333     Document Type: Article

References (84)

1. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120, 885-890.
2. Fiala JC (2007) Mechanisms of amyloid plaque pathogenesis. Acta Neuropathol 114, 551-571.
3. Thal DR, Capetillo-Zarate E, Del Tredici K, Braak H (2006) The development of amyloid beta protein deposits in the aged brain. Sci Aging Knowledge Environ 6, 1-9.
4. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
5. Glabe CG (2008) Structural classification of toxic amyloid oligomers. J Biol Chem 283, 29639-29643.
6. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46, 860-866.
7. Dahlgren KN, Manelli AM, Stine WB, Jr., Baker LK, Krafft GA, LaDu MJ (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277, 32046-32053.
8. Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ (1999) Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19, 8876-8884.
9. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95, 6448-6453.
10. Zhang Y, McLaughlin R, Goodyer C, LeBlanc A (2002) Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons. J Cell Biol 156, 519-529.
11. Cleary JP,Walsh DM, Hofmeister JJ, Shankar GM,Kuskowski MA, Selkoe DJ, Ashe KH (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8, 79-84.
12. Klyubin I,Walsh DM, Lemere CA, Cullen WK, Shankar GM, Betts V, Spooner ET, Jiang L, Anwyl R, Selkoe DJ, Rowan MJ (2005) Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat Med 11, 556-561.
13. Knobloch M, Konietzko U, Krebs DC, Nitsch RM (2007) Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. Neurobiol Aging 28, 1297-1306.
14. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
15. Knobloch M, Farinelli M, Konietzko U, Nitsch RM, Mansuy IM (2007) Abeta oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms. J Neurosci 27, 7648-7653.
16. Fiala JC, FeinbergM, Peters A, Barbas H (2007) Mitochondrial degeneration in dystrophic neurites of senile plaques may lead to extracellular deposition of fine filaments. Brain Struct Funct 212, 195-207.
17. Giannakopoulos P, Hof PR, Michel JP, Guimon J, Bouras C (1997) Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res Brain Res Rev 25, 217-245.
18. Peters A (2002) Structural changes in the normally aging cerebral cortex of primates. Prog Brain Res 136, 455-465.
19. Price DL, Martin LJ, Sisodia SS,WagsterMV,Koo EH,Walker LC,Koliatsos VE, Cork LC (1991) Aged non-human primates: an animal model of age-associated neurodegenerative disease. Brain Pathol 1, 287-296.
20. Armstrong DM, Hersh LB, Gage FH (1988) Morphologic alterations of cholinergic processes in the neocortex of aged rats. Neurobiol Aging 9, 199-205.
21. Jucker M, Ingram DK (1997) Murine models of brain aging and age-related neurodegenerative diseases. Behav Brain Res 85, 1-26.
22. Jucker M,Walker LC,KuoH, Tian M, IngramDK(1994) Agerelated fibrillar deposits in brains of C57BL/6 mice. A review of localization, staining characteristics, and strain specificity. Mol Neurobiol 9, 125-133.
23. Lamar CH, Hinsman EJ, Henrikson CK (1976) Alterations in the hippocampus of aged mice. Acta Neuropathol (Berl) 36, 387-391.
24. Mandybur TI, Ormsby I, Zemlan FP (1989) Cerebral aging: a quantitative study of gliosis in old nude mice. Acta Neuropathol (Berl) 77, 507-513.
25. Vaughan DW, Peters A (1981) The structure of neuritic plaque in the cerebral cortex of aged rats. J Neuropathol Exp Neurol 40, 472-487.
26. Knuesel I, Nyffeler M, Mormede C, Muhia M, Meyer U, Pietropaolo S, Yee BK, Pryce CR, LaFerla FM, Marighetto A, Feldon J (2009) Age-related accumulation of Reelin in amyloid-like deposits. Neurobiol Aging 30, 697-716.
27. Rice DS, Curran T (2001) Role of the reelin signaling pathway in central nervous system development. Annu Rev Neurosci 24, 1005-1039.
28. D'Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T (1995) A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374, 719-723.
29. D'Arcangelo G, Nakajima K, Miyata T, Ogawa M, Mikoshiba K, Curran T (1997) Reelin is a secreted glycoprotein recognized by the CR-50 monoclonal antibody. J Neurosci 17, 23-31.
30. de Bergeyck V, Nakajima K, Lambert de Rouvroit C, Naerhuyzen B, Goffinet AM, Miyata T, Ogawa M, Mikoshiba K (1997) A truncated Reelin protein is produced but not secreted in the 'Orleans' reeler mutation (Reln [rl-Orl]). Brain Res Mol Brain Res 50, 85-90.
31. Nakano Y, Kohno T, Hibi T, Kohno S, Baba A, Mikoshiba K, Nakajima K, Hattori M (2007) The extremely conserved C-terminal region of Reelin is not necessary for secretion but is required for efficient activation of downstream signaling. J Biol Chem 282, 20544-20552.
32. Lambert de Rouvroit C, de Bergeyck V, Cortvrindt C, Bar I, Eeckhout Y, Goffinet AM (1999) Reelin, the extracellular matrix protein deficient in reeler mutant mice, is processed by a metalloproteinase. Exp Neurol 156, 214-217.
33. Herz J, ChenY(2006) Reelin, lipoprotein receptors and synaptic plasticity. Nat Rev Neurosci 7, 850-859.
34. Beffert U, Durudas A,Weeber EJ, Stolt PC, Giehl KM, Sweatt JD, Hammer RE, Herz J (2006) Functional dissection of Reelin signaling by site-directed disruption of Disabled-1 adaptor binding to apolipoprotein E receptor 2: distinct roles in development and synaptic plasticity. J Neurosci 26, 2041-2052.
35. Beffert U, Weeber EJ, Durudas A, Qiu S, Masiulis I, Sweatt JD, Li WP, Adelmann G, Frotscher M, Hammer RE, Herz J (2005) Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron 47, 567-579.
36. Chen Y, Beffert U, Ertunc M, Tang TS, Kavalali ET, Bezprozvanny I, Herz J (2005) Reelin modulates NMDA receptor activity in cortical neurons. J Neurosci 25, 8209-8216.
37. Hoe HS, Lee KJ, Carney RS, Lee J, Markova A, Lee JY, Howell BW, Hyman BT, Pak DT, Bu G, Rebeck GW (2009) Interaction of reelin with amyloid precursor protein promotes neurite outgrowth. J Neurosci 29, 7459-7473.
38. Hoe HS, Tran TS, Matsuoka Y, Howell BW, Rebeck GW (2006) Dab1 and Reelin effects on APP and ApoEr2 trafficking and processing. J Biol Chem 281, 35176-35185.
39. Beffert U, Weeber EJ, Morfini G, Ko J, Brady ST, Tsai LH, Sweatt JD, Herz J (2004) Reelin and cyclin-dependent kinase 5-dependent signals cooperate in regulating neuronal migration and synaptic transmission. J Neurosci 24, 1897-1906.
40. Hiesberger T, TrommsdorffM, Howell BW, Goffinet A, Mumby MC, Cooper JA, Herz J (1999) Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24, 481-489.
41. Ohkubo N, Lee YD, Morishima A, Terashima T, Kikkawa S, Tohyama M, Sakanaka M, Tanaka J, Maeda N, Vitek MP, Mitsuda N (2003) Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade. FASEB J 17, 295-297.
42. D'Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M, Curran T (1999) Reelin is a ligand for lipoprotein receptors. Neuron 24, 471-479.
43. Zheng H, Jiang M, Trumbauer ME, Sirinathsinghji DJ, Hopkins R, Smith DW, Heavens RP, Dawson GR, Boyce S, Conner MW, Stevens KA, Slunt HH, Sisoda SS, Chen HY, Van der Ploeg LH (1995) beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81, 525-531.
44. Bar I, Lambert De Rouvroit C, Royaux I, Krizman DB, Dernoncourt C, Ruelle D, Beckers MC, Goffinet AM (1995) A YAC contig containing the reeler locus with preliminary characterization of candidate gene fragments. Genomics 26, 543-549.
45. Hirotsune S, Takahara T, Sasaki N, Hirose K, Yoshiki A, Ohashi T, Kusakabe M, Murakami Y, Muramatsu M, Watanabe S, et al. (1995) The reeler gene encodes a protein with an EGF-like motif expressed by pioneer neurons. Nat Genet 10, 77-83.
46. Takahara T, Ohsumi T, Kuromitsu J, Shibata K, Sasaki N, Okazaki Y, Shibata H, Sato S, Yoshiki A, Kusakabe M, Muramatsu M, Ueki M, Okuda K, Hayashizaki Y (1996) Dysfunction of the Orleans reeler gene arising from exon skipping due to transposition of a full-length copy of an active L1 sequence into the skipped exon. Hum Mol Genet 5, 989-993.
47. Paxinos G, Franklin K (2001) The mouse brain in stereotaxic coordinates. Academic Press, Second Edition.
48. Nyffeler M, Zhang WN, Feldon J, Knuesel I (2007) Differential expression of PSD proteins in age-related spatial learning impairments. Neurobiol Aging 28, 143-155.
49. Chin J, Massaro CM, Palop JJ, Thwin MT, Yu GQ, Bien-Ly N, Bender A, Mucke L (2007) Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. J Neurosci 27, 2727-2733.
50. Miettinen R, Riedel A, Kalesnykas G, Kettunen HP, Puolivali J, Soininen H, Arendt T (2005) Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy. J Chem Neuroanat 30, 105-118.
51. Ramos-Moreno T, Galazo MJ, Porrero C, Martinez-Cerdeno V, Clasca F (2006) Extracellular matrix molecules and synaptic plasticity: immunomapping of intracellular and secreted Reelin in the adult rat brain. Eur J Neurosci 23, 401-422.
52. Pappas GD, Kriho V, Liu WS, Tremolizzo L, Lugli G, Larson J (2003) Immunocytochemical localization of reelin in the olfactory bulb of the heterozygous reeler mouse: an animal model for schizophrenia. Neurol Res 25, 819-830.
53. Pappas GD, Kriho V, Pesold C (2001) Reelin in the extracellular matrix and dendritic spines of the cortex and hippocampus: a comparison between wild type and heterozygous reeler mice by immunoelectron microscopy. J Neurocytol 30, 413-425.
54. Van Dooren T, Muyllaert D, Borghgraef P, Cresens A, Devijver H, Van der Auwera I, Wera S, Dewachter I, Van Leuven F (2006) Neuronal or glial expression of human apolipoprotein e4 affects parenchymal and vascular amyloid pathology differentially in different brain regions of double- and tripletransgenic mice. Am J Pathol 168, 245-260.
55. Mayeux R, Tang MX, Jacobs DM, Manly J, Bell K, Merchant C, Small SA, Stern Y, Wisniewski HM, Mehta PD (1999) Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease. Ann Neurol 46, 412-416.
56. Hilbich C, Monning U, Grund C, Masters CL, Beyreuther K (1993) Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11. J Biol Chem 268, 26571-26577.
57. Dooley NP, Gauthier S, Durham HD (1992) Antibody to beta-amyloid precursor protein recognizes an intermediate filament-associated protein in Alzheimer's and control fibroblasts. J Neurosci Res 33, 60-67.
58. Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M (2009) APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457, 981-989.
59. Muresan Z, Muresan V (2004) A phosphorylated, carboxyterminal fragment of beta-amyloid precursor protein localizes to the splicing factor compartment. Hum Mol Genet 13, 475-488.
60. Chang WP, Koelsch G, Wong S, Downs D, Da H, Weerasena V, Gordon B, Devasamudram T, Bilcer G, Ghosh AK, Tang J (2004) In vivo inhibition of Abeta production by memapsin 2 (beta-secretase) inhibitors. J Neurochem 89, 1409-1416.
61. Haenggi T, Schaub MC, Fritschy JM (2005) Molecular heterogeneity of the dystrophin-associated protein complex in the mouse kidney nephron: differential alterations in the absence of utrophin and dystrophin. Cell Tissue Res 319, 299-313.
62. Haenggi T, Fritschy JM (2006) Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue. Cell Mol Life Sci 63, 1614-1631.
63. Sassoe-Pognetto M, Wassle H, Grunert U (1994) Glycinergic synapses in the rod pathway of the rat retina: cone bipolar cells express the alpha 1 subunit of the glycine receptor. J Neurosci 14, 5131-5146.
64. Fung J, Frost D, Chakrabartty A, McLaurin J (2004) Interaction of human and mouse Abeta peptides. J Neurochem 91, 1398-1403.
65. Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K (1991) Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4. Eur J Biochem 201, 61-69.
66. Watanabe M, Fukaya M, Sakimura K, Manabe T, Mishina M, Inoue Y (1998) Selective scarcity of NMDA receptor channel subunits in the stratum lucidum (mossy fibre-recipient layer) of the mouse hippocampal CA3 subfield. Eur J Neurosci 10, 478-487.
67. Peters A, Palay S, Webster H (1991) The fine structure of the nervous system: Neurons and their supporting cells. Oxford University Press, Third Edition.
68. Shivers BD, Hilbich C, Multhaup G, Salbaum M, Beyreuther K, Seeburg PH (1988) Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J 7, 1365-1370.
69. Yamada T, Sasaki H, Furuya H, Miyata T, Goto I, Sakaki Y (1987) Complementary DNA for the mouse homolog of the human amyloid beta protein precursor. Biochem Biophys Res Commun 149, 665-671.
70. Jarrett JT, Lansbury PT, Jr. (1993) Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058.
71. Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K (1991) Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J Mol Biol 218, 149-163.
72. Ryle AP, Auffret CA (1979) The specificity of some pig and human pepsins towards synthetic peptide substrates. Biochem J 179, 247-249.
73. Dunn BM (2002) Structure and mechanism of the pepsin-like family of aspartic peptidases. Chem Rev 102, 4431-4458.
74. Roberts RC, Xu L, Roche JK, Kirkpatrick B (2005) Ultrastructural localization of reelin in the cortex in post-mortem human brain. J Comp Neurol 482, 294-308.
75. Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26, 267-298.
76. Kubo K, Mikoshiba K, Nakajima K (2002) Secreted Reelin molecules form homodimers. Neurosci Res 43, 381-388.
77. Utsunomiya-Tate N, Kubo K, Tate S, Kainosho M, Katayama E, Nakajima K, Mikoshiba K (2000) Reelin molecules assemble together to form a large protein complex, which is inhibited by the function-blocking CR-50 antibody. Proc Natl Acad Sci U S A 97, 9729-9734.
78. Strasser V, Fasching D, Hauser C, Mayer H, Bock HH, Hiesberger T, Herz J,Weeber EJ, Sweatt JD, Pramatarova A, Howell B, Schneider WJ, Nimpf J (2004) Receptor clustering is involved in Reelin signaling. Mol Cell Biol 24, 1378-1386.
79. Yasui N, Nogi T, Kitao T, Nakano Y, Hattori M, Takagi J (2007) Structure of a receptor-binding fragment of reelin and mutational analysis reveal a recognition mechanism similar to endocytic receptors. Proc Natl Acad Sci US A 104, 9988-9993.
80. Wirths O, Multhaup G, Czech C, Blanchard V, Tremp G, Pradier L, Beyreuther K, Bayer TA (2001) Reelin in plaques of beta-amyloid precursor protein and presenilin-1 doubletransgenic mice. Neurosci Lett 316, 145-148.
81. Riedel A, Miettinen R, Stieler J, Mikkonen M, Alafuzoff I, Soininen H, Arendt T (2003) Reelin-immunoreactive Cajal- Retzius cells: the entorhinal cortex in normal aging and Alzheimer's disease. Acta Neuropathol (Berl) 106, 291-302.
82. Baloyannis SJ (2005) Morphological and morphometric alterations of Cajal-Retzius cells in early cases of Alzheimer's disease: a Golgi and electron microscope study. Int J Neurosci 115, 965-980.
83. Botella-Lopez A, Burgaya F, Gavin R, Garcia-Ayllon MS, Gomez-Tortosa E, Pena-Casanova J, Urena JM, Del Rio JA, Blesa R, Soriano E, Saez-Valero J (2006) Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc Natl Acad Sci U S A 103, 5573-5578.
84. Saez-Valero J, Costell M, Sjogren M, Andreasen N, Blennow K, Luque JM (2003) Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease. J Neurosci Res 72, 132-136.